RxDoctor Payments Data

Kira Vurlicer

Family Medicine · Princeton, NCNPI 1396707592

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 136 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Novo Nordisk at 44.3% of the total. Reporting peaked in 2022 at $570 and has fallen 71.1% since, to $165 in 2023.

$2,004in general payments, 2019–2025

Across 136 payments — averaging $14.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$887
  • Lilly USA, LLC$331
  • Gilead$215
  • Amgen$78
  • Boehringer Ingelheim$74
  • Sanofi-aventis U.S. LLC$70
  • plus $347 from 8 others

What the payments were for

  • Food & beverage$2,004100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,004 in reported general payments places this provider in the 80th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina →

Other family medicine in Princeton

See the full list for North Carolina →

Where these figures come from

Is this you, or does something look wrong? →